Multiple Assemblies exist for SMTL entry 5qch
Crystal structure of human Cathepsin-S with bound ligand; X-RAY DIFFRACTION 2.20 Å

	SMTL ID 5qch.1 Ligands SULFATE ION; 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide Polypeptides Cathepsin S Oligo-state monomer
	SMTL ID 5qch.2 Ligands SULFATE ION; GLYCEROL; 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide Polypeptides Cathepsin S Oligo-state monomer
	SMTL ID 5qch.3 Ligands SULFATE ION; 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide Polypeptides Cathepsin S Oligo-state monomer
	SMTL ID 5qch.4 Ligands SULFATE ION; GLYCEROL; 2-(3-[3-({3-[(benzylamino)methyl]-4-chlorophenyl}ethynyl)-4-chlorophenyl]-1-{3-[(3S)-3-methylmorpholin-4-yl]propyl}-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)-2-oxoacetamide Polypeptides Cathepsin S Oligo-state monomer